PUBLICATIONS
PEER REVIEWED ORIGINAL ARTICLES
1.
Nayan G Patel, Sudhesh Kumar, Margaret C Eggo. Essential Role of FGF
Signalling in Pre-Adipocyte Differentiation.
Journal of Clinical
Endocrinology & Metabolism. September 2004 – in press.
2.
Counterweight Project Team. A new evidence-based model for weight
management in primary care: The Counterweight Programme. J Hum Nutr
Dietet, 2004, 17, pp 191-208.
3.
Counterweight Project Team. Current approaches to obesity management in
UK Primary Care: The Counterweight Programme. J Hum Nutr Dietet,
2004, 17, pp 183-190.
4.
G. Valsamakis, R. Chetty, A. Anwar, A.K. Banerjee, A. Barnett, S. Kumar.
Association of simple anthropometric measures of obesity with visceral fat and
the metabolic syndrome in male caucasian and Indo-Asian subjects. Diabetic
Medicine in press 2004
5.
G.Valsamakis, A. Anwar, J. Tomlinson, CHL Shackleton, PG
McTernan, R. Chetty, AK Banerjee, G Holder, AH Barnett, PM Stewart, S.
Kumar. 11beta hydroxysteroid dehydrogenase type 1 activity in lean and
obese patients with type 2 diabetes mellitus. J Clin Endo Metab Sep 2004,
89(9): 4755-61.
6.
Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett
AH, Kumar S. Modest weight loss and reduction in waist circumference after
medical treatment are associated with favorable changes in serum
adipocytokines. Metabolism.; April 2004 53(4):430-4.
7.
O’Hare JP, Raymond NT, Mughal S, Dodd L, Hanif W, Ahmed Y, Mishra K,
Jones A, Kumar S, Szczepura A, Hillhouse EW and Barnett AH, on behalf of
the UKADS study group. Re Evaluation of delivery of enhanced diabetes care
to patients of South Asian ethnicity: The United Kingdom Asian Diabetes
Study (UKADS). Diabetic Medicine, in press 2004.
8.
Anthony Barnett, D John Betteridge, Christopher Byrne, Nigel Capps, Robert
Elkeles, Michael Feher, Gordon Ferns, Liz Hughes, Graham Jackson,
Sudhesh Kumar,, Dimitri Mikhailidis, Paul Miller, Chris Packard, Vinod Patel,
John Reckless, Alan Rees, Anthony Wierzbicki, Richard Wray, John Wright,
Ian Young. Role of fibrates in reducing coronary risk: a UK consensus.
Current Medical Research and Opinion, Vol 20 (No 2), 2004: pp 241-247.
9.
Gibbs, HD, Broom J, Brown J Laws RA, Reckless JPD, Noble PA, Kumar S,
McCombie EL, Lean MEJ, Lyons GF, Frost GS, Quinn MF, Barth JH, Haynes
SM, Finer N Ross HM, Hole DJ, Montazeri, A. Audit data on current GP
practice for obesity management. Journal of Human Nutrition and Dietetics,
in press, April 2004.
10.
Gibbs, HD, Broom J, Brown J Laws RA, Reckless JPD, Noble PA, Kumar S,
McCombie EL, Lean MEJ, Lyons GF, Frost GS, Quinn MF, Barth JH, Haynes
SM, Finer N Ross HM, Hole DJ, Montazeri, A. A new evidence based model
for weight management in primary care: The Counterweight Programme.
Journal of Human Nutrition and Dietetics,Vol 17 (No 3) June 2004, pp 191280(18).
11.
Harte AL, McTernan PG, McTernan CL, Crocker J, Starcynski J, Barnett AH,
Matyka K, Kumar S. Insulin increases angiotensinogen expression in human
abdominal subcutaneous adipocytes. Diabetes Obes Metab. 2003 Nov;
5(6):462-7.
12.
Al-Daghri N, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, Kumar S.
Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome
and coronary artery disease. Diabetic Medicine. 2003 Oct; 20(10):832-7.
13.
Harte A, McTernan P, McTernan C, Smith S, Barnett A, Kumar S.
Rosiglitazone inhibits the insulin-mediated increase in PAI-1 secretion in
human abdominal subcutaneous adipocytes. Diabetes, Obesity &
Metabolism 2003;5:302-10.
14.
Peter P, Kumar S. Management of the overweight patient with Type 2
diabetes.Diabet Med. 2003 Sep; 20 Suppl 4:10-3.
15.
Tica V, Hanif M.W., Andersson A, Valsamakis G, Barnett A.H., Kumar S,
Sanjeevi C.B. Frequency of Latent Autoimmune Diabetes in Adults in Asian
Patients Diagnosed as Type 2 Diabetes in Birmingham, United Kingdom.
Annals of the New York Academy of Sciences: Immunology of Diabetes II,
Pathogenesis from Mouse to Man 2003; 1005: 356-359.
16.
Palin S, McTernan P, Anderson L.A., Sturdee D.W., Barnett A.H., Kumar S.
17-beta-estradiol and anti-estrogen ICI: compund 182,780 regulates
expression of lipoprotein lipase and hormone-sensitive lipase in isolated
subcutaneous abdominal adipocytes. Metabolism 2003;52:383-8.
17.
Patel N, Holder J, Smith SA, Kumar S, Eggo MC. Differential regulation of
lipogenesis and leptin production by different signalling pathways and
rosiglitazone during human adipocyte differentiation. Diabetes 2003; 52:4350.
18.
Shakher A, McTernan P, Kumar S. Obesity. In Haegerty A, Tomlinson S,
Weetman A, Malik R, eds. Mechanisms of Disease, Cambridge, 2003.
19.
Fisher MF, McTernan PG, Harte A, Valsamakis G, Chetty R, Barnett AH,
Kumar S. Expression of adiponectin gene and protein in human adipose tissue
depots: reduced expression in abdominal fat depots and in diabetes.
Hormone Research & Metabolism, In press 2003.
20.
Philip G. McTernan, FFolliott M. Fisher, George Valsamakis, Rajkumar Chetty,
Alison Harte, Claire L. McTernan, Penny M. S. Clark, Stephen A. Smith,
Anthony H. Barnett and Sudhesh Kumar. Resistin and Type 2 Diabetes:
Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects
of Recombinant Resistin on Lipid and Glucose Metabolism in Human
Differentiated Adipocytes. The Journal of Clinical Endocrinology & Metabolism
2003; Vol. 88, No. 12: 6098-6106.
21.
Valsamakis G, Chetty R, McTernan P, Al-Daghri N, Jones A, Kumar S. Fasting
serum adiponectin concentration is reduced in Indo-Asians and is related to
HDL cholesterol. Diabetes, Obesity & Metabolism 2003;5:131-5.
22.
Palin S, McTernan PG, Anderson LA, Barnett AH, Kumar S 17-beta-estradiol
and anti-estrogen ICI: Compound 182,780 regulates expression of lipoprotein
lipase and hormone-sensitive lipase in isolated subcutaneous abdominal
adipocytes. Metabolism, ; 52(4):383-388.
23.
McTernan PG,. Harte AL,. Andersonn LA, Green A,. Smith S A,. Holder J C,.
Barnett A H,. Eggo M C and Kumar S. Insulin and Rosiglitazone Regulation of
Lipolysis and Lipogenesis in Human Adipose Tissue in vitro. Diabetes 2002;
51:1493-1498
24.
Anderson AL, McTernan PG, Harte AL, Barnett AH, Kumar S. The regulation
of HSL and LPL expression by DHT and Flutamide in Human Subcutaneous
adipose tissue. Diabetes, Obesity & Metabolism, 2002; 4:209-214.
25.
McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher fM, Lauer MN, Crocker
J, Barnett AH, Kumar S. Increased Resistin Gene and Protein Expression in
Human Abdominal Adipose Tissue. Journal of Clinical Endocrinology &
Metabolism, 2002; 87(5):2407-2410.
26.
McTernan C.L, McTernan P.G., Harte A.L., Barnett A.H., Kumar S. Resistin-The
link between central obesity and type 2 diabetes? Lancet. 2002;359:46-7.
27.
Al-Nozha M, Al-Daghri N, Bartlett WB, Al-Maatouq M, Al-Attas O, Kumar S,
Jones AF. Serum Homocysteine concentration is related to diabetes mellitus
but not to coronary artery disease in a Saudi population. Diabetes, Obesity
and Metabolism, 2002;4(2):118-23.
28.
McTernan P.G., Anwar A., Anderson L., Eggo M. C, Barnett A.H., Stewart P.M.,
Kumar S. Gender and site specific regulation of aromatase activity in human
adipose tissue. J Clin Endocrinol & Metab . 2002 Mar;87(3):1327-36.
29.
Palin SL, McTernan PG, Sturdee DW, Barnett AH, Kumar S. Dydrogesterone
and norethisterone regulate expression of lipoprotein lipase and hormone
sensitive lipase in isolated human adipocytes. Metabolism In press 2002.
30.
Al-Daghri N, Jones AF, Bartlett B, Kumar S. Role of leptin in glucose
metabolism in type 2 diabetes. Diabetes, Obesity and Metabolism, 4, 2002,
147-155.
31.
Fisher ff M, McTernan P G, Valsamakis G, Chetty R, Harte A L , Anwar A J,
Starcynski J, Crocker, J, Barnett A J, McTernan C L , Kumar S. Differences
in Adiponectin Protein expression: Effect of fat depots and type 2 diabetic
status. Horm Metabl Res 2002: 34: 650-654.
32.
Valsamakis G, Chetty R, Kumar S. The management of obesity in type 2
diabetes mellitus. Curr Med Res and Opinion: 2002; 18(1): s75-81.
33.
Valsamakis G, Kumar S. Is sibutramine more than a slim hope? Drug and
Ther Bulletin. 39(12): 89-92.